Special Analysis: Addressing Key Concerns Around the FDA’s Final LDTs Rule
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
What happens when lab personnel’s OSHA rights to access illness and injury records seemingly clash with HIPAA privacy laws?
New OIG Advisory Opinion offers valuable insight into where the agency draws the line on free genetic tests.
Of this month’s four Labs in Court cases, three involved kickbacks resulting in widely varying penalties.
A briefing of the current requirements you can use to avoid billing and coding errors at your own lab or pathology practice.
A newly finalized local coverage determination from MAC Palmetto GBA sets out coverage criteria for two applications of these tests.
Key points to educate your staff on when it comes to patient requests for test records and other protected health information.
In this month’s key cases, Myriad Genetics shells out, Illumina wins a decisive victory, a whistleblower suit is tossed, and false billing of UDTs costs a lab at least $11.6 million.
This script helps prepare frontline staff to answer questions that patients seeking access to their PHI are likely to ask.
An overview of the rules and requirements to help you keep your reference laboratory billing arrangements compliant.
The DOJ recently charged 21 defendants across the US for allegedly carrying out COVID-19 scams worth just under $150 million.